Equity in net income/(loss) of
unconsolidated partnerships 43 (454) (130) (432)
Interest income 106 339 261 570
Interest expense (8,629) (7,117) (15,566) (13,969)
Income from continuing
operations before
minority interests 18,946 17,773 36,334 38,344
Minority interests in
continuing operations of
consolidated partnerships (1) (113) 7 (113)
Minority interests in continuing
operations of operating
partnership (619) (577) (1,209) (1,276)
Income from continuing
operations 18,326 17,083 35,132 36,955
Income from discontinued
operations before gain on sale
of assets and minority
interests - 252 - 639
Gain on sale of real estate
assets - 1,088 - 1,088
Minority interests attributable
to discontinued operations - (57) - (74)
Income from discontinued
operations - 1,283 - 1,653
Net income 18,326 18,366 35,132 38,608
Preferred stock dividends (4,241) (4,194) (8,481) (8,387)
Net income available to
common stockholders $14,085 $14,172 $26,651 $30,221
Income from continuing
operations per share available
to common stockholders:
Basic and diluted earnings per
share $0.20 $0.20 $0.39 $0.44
Net income per share available to
common stockholders:
Basic and diluted earning
'/>"/>
| SOURCE BioMed Realty Trust, Inc. Copyright©2008 PR Newswire. All rights reserved |